B. Kelley

发表

Recombinant human factor VIII-specific affinity ligands selected from phage-displayed combinatorial libraries of protein A.

M. Uhlén, P. Nygren, K. Nord, 2001, European journal of biochemistry.

1 DOWNSTREAM PROCESSING OF MONOCLONAL ANTIBODIES : CURRENT PRACTICES AND FUTURE OPPORTUNITIES

B. Kelley, 2017 .

Industrial Animal Cell Culture

Daniel I. C. Wang, T. Chiou, B. Kelley, 2001 .

Viral clearance studies on new and used chromatography resins: critical review of a large dataset.

B. Kelley, J. Jakubik, S. Vicik, 2008, Biologicals : journal of the International Association of Biological Standardization.

Procédés de purification de polypeptides

B. Kelley, Hui F. Liu, K. Petty, 2011 .

Transmissible spongiform encephalopathy agent clearance by the immunoaffinity and anion‐exchange chromatography steps of the ReFacto® manufacturing process

B. Kelley, S. Vicik, C. Gallo, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

The manufacturing process for B-domain deleted recombinant factor VIII.

M. Leonard, B. Kelley, C. Ljungqvist, 2001, Seminars in hematology.

Exploration of overloaded cation exchange chromatography for monoclonal antibody purification.

B. Kelley, R. van Reis, A. Amanullah, 2011, Journal of chromatography. A.

Protein Purification by Liquid‐Liquid Extraction

T. A. Hatton, B. Kelley, T. Hatton, 2001 .

The manufacturing process for recombinant factor IX.

K. Hanley, M. McCarthy, M. Leonard, 1998, Seminars in hematology.

Viral safety of B-domain deleted recombinant factor VIII.

M. Jernberg, B. Kelley, T. Charlebois, 2001, Seminars in hematology.

Characterization of a major xylanase purified from Lentinula edodes cultures grown on a commercial solid lignocellulosic substrate

G. F. Leatham, R. Burgess, Chittra Mishra, 1990, Applied Microbiology and Biotechnology.

High-throughput screening of chromatographic separations: I. Method development and column modeling.

B. Kelley, Brian D Kelley, Jack F. Kramarczyk, 2008, Biotechnology and bioengineering.

Characteristics and N-terminal amino acid sequence of a manganese peroxidase purified from Lentinula edodes cultures grown on a commercial wood substrate

G. F. Leatham, W. N. Strickland, R. Burgess, 1990, Applied Microbiology and Biotechnology.

High-throughput screening of chromatographic separations: III. Monoclonal antibodies on ceramic hydroxyapatite.

B. Kelley, David L Wensel, Brian D Kelley, 2008, Biotechnology and bioengineering.

High‐throughput screening of chromatographic separations: II. Hydrophobic interaction

Brian D. Kelley, B. Kelley, Jack F. Kramarczyk, 2008, Biotechnology and bioengineering.

Effect of Inclusion Body Contaminants on the Oxidative Renaturation of Hen Egg White Lysozyme

B. Kelley, Jhansi Maachupalli‐Reddy, E. D. Clark, 1997, Biotechnology progress.

Affinity–based reversed micellar protein extraction: I. Principles and protein–ligand systems

T. A. Hatton, Daniel I. C. Wang, B. Kelley, 1993, Biotechnology and bioengineering.

Affinity‐based reversed micellar protein extraction: II. Effect of cosurfactant tail length

T. A. Hatton, B. Kelley, Daniel I. C. Wang, 1993, Biotechnology and bioengineering.

Scale-Down Models for Purification Processes: Approaches and Applications

Brian D. Kelley, Ranga Godavarti, B. Kelley, 2005 .

Very Large Scale Monoclonal Antibody Purification: The Case for Conventional Unit Operations

Brian Kelley, B. Kelley, 2007, Biotechnology progress.

High‐throughput screening of chromatographic separations: IV. Ion‐exchange

Jon Coffman, Mary Switzer, K. Molnar, 2008, Biotechnology and bioengineering.

Effect of protein and solution properties on the donnan effect during the ultrafiltration of proteins

Jonida Basha, B. Kelley, H. Acharya, 2011, Biotechnology progress.

Isolation of a peptide ligand for affinity purification of factor VIII using phage display.

R. Ladner, A. Ley, B. Kelley, 2004, Journal of chromatography. A.

DOWNSTREAM PROCESSING OF MONOCLONAL ANTIBODIES: CURRENT PRACTICES AND FUTURE OPPORTUNITIES

Brian D. Kelley, B. Kelley, Greg S. Blank, 2008 .

Development and validation of an affinity chromatography step using a peptide ligand for cGMP production of factor VIII

Robert Magnusson, R. Magnusson, B. Kelley, 2004, Biotechnology and bioengineering.

Quantitative Comparison of Global Carbohydrate Structures of Glycoproteins Using LC−MS and In-Source Fragmentation

B. Kelley, I. Mazsaroff, J. Vath, 1997 .

The rapid identification of elution conditions for therapeutic antibodies from cation-exchange chromatography resins using high-throughput screening.

Philip Lester, B. Kelley, Paul J. Mcdonald, 2016, Journal of chromatography. A.

Quantitative comparison of global carbohydrate structures of glycoproteins using LC-MS and in-source fragmentation.

W. Yu, B. Kelley, I. Mazsaroff, 1997, Analytical Chemistry.

West Nile Virus inactivation by the solvent/detergent steps of the second and third generation manufacturing processes for B‐domain deleted recombinant factor VIII

B. Kelley, J J Jakubik, S M Vicik, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Robustness Testing of a Chromatographic Purification Step Used in Recombinant Factor IX Manufacture

Brian D. Kelley, Brian Hubbard, Lei Shi, 1998 .